The identification of the genetic basis of approximately half of the corneal dystrophies in the past decade has resulted in significant advances in our understanding of the genetic control of corneal clarity and has provided clinicians with a definitive means to confirm or refute presumptive clinical diagnoses. This article serves as a guide to understanding the genetic basis of the corneal dystrophies and provides a revised anatomically based classification system that is intended for the clinician, who must possess a working knowledge of the molecular genetic basis of the corneal dystrophies to accurately diagnose,counsel, and manage the disease in affected patients.
Significant advances have been made in the past decade in our understanding of the genetic basis of inherited ocular disorders. The genetic basis of approximately half of the corneal dystrophies has been identified (Table 1), and a chromosomal locus has been described for several others. Dystrophies once thought to be distinct entities based on characteristic clinical and histopathologic features are now known to share a common genetic basis and in some cases are even associated with mutations involving the same codon (Table 2). The clinician is now able to use molecular genetic analysis to confirm or refute presumptive clinical diagnoses in cases of suspected dystrophic corneal disorders.1,2
However, with the ability to definitively diagnose various corneal dystrophies has come a realization that many previous assumptions about the corneal dystrophies are no longer valid. For example, although a dominantly inherited corneal dystrophy would have been considered an unlikely diagnosis in the affected offspring of unaffected parents, mutation screening has confirmed the diagnosis of a highly penetrant, dominantly inherited dystrophy in cases of spontaneous pathogenic mutations.3 In addition, the accepted means of differentiating between the corneal dystrophies on the basis of characteristic clinical features has been challenged by the observance of significant interfamilial and even intrafamilial phenotypic variability among affected individuals sharing a common mutation.4-6 Even the definition of a corneal dystrophy has been challenged in this new era of molecular genetics, as we are now able to confirm the diagnosis of a corneal dystrophy in cases associated with an atypical phenotype, such as unilateral dystrophies,7-11 dystrophies that involve more than a single layer of the cornea,5,12 and dystrophies that are associated with extraocular involvement.12-14 Identification of the genetic basis of the corneal dystrophies and characterization of the expressed protein product have led to insights such as the fact that the transforming growth factor β–induced protein (TGFBI) dystrophies, which involve the Bowman layer and stroma, may actually be of an epithelial genesis.15-17 This, as well as the characterization of several dystrophies that involve multiple layers of the cornea,5,12 highlights the limitations of the current method of classifying the corneal dystrophies by anatomic level of involvement. Thus, although we know much more about the molecular genetic basis of the corneal dystrophies than we did a decade ago,we are now confronted with even more questions about the role of the genetic background and environmental influences in determining the phenotypic expression of the corneal dystrophies, how to categorize and differentiate between the corneal dystrophies, and even how to define a corneal dystrophy. This article will serve as a guide to the current understanding of the molecular genetic basis of the corneal dystrophies, will provide a revised framework for classifying the corneal dystrophies, and will provide information regarding how molecular genetic analysis can be incorporated into everyday clinical practice to enhance the clinician's ability to differentiate between dystrophic and nondystrophic corneal disorders.
Despite the limitations of an anatomically based classification system for the corneal dystrophies, it remains the most useful means of categorizing the corneal dystrophies for the clinician. Given the ease of examining the cornea, in terms of its forming the anterior ocular surface and being a transparent tissue, the clinician is typically able to determine the precise morphological nature and location of the dystrophic deposits. The pattern of dystrophic deposition and the level of anatomic involvement typically determine the affected individual's associated symptoms. Dystrophies of the corneal epithelium and the Bowman layer are commonly associated with recurrent epithelial erosions and decreased visual acuity secondary to epithelial irregularity and scarring of the Bowman layer; stromal dystrophies produce decreased visual acuity by the deposition of various substances in the keratocytes or the extracellular matrix, in a localized manner or in association with systemic accumulation;and the dystrophies of the Descemet membrane and corneal endothelium impair visual acuity by interfering with the endothelial pump function, leading to corneal edema. Although exceptions exist to these generalizations, they illustrate the utility of an anatomically based classification system for the corneal dystrophies. Even when molecular genetic characterization of each of the corneal dystrophies is complete, the primary means of classifying the corneal dystrophies will likely be clinical, although such a classification will certainly incorporate histopathologic and molecular genetic features of the dystrophies. Thus, the classification system that appears herein, in the text and in tabular form (Table 1), presents the corneal dystrophies in a way that we hope will be useful to the clinician, who must possess knowledge of the molecular genetic basis of the corneal dystrophies to accurately diagnose,counsel, and manage the disease in affected patients.
Dystrophies of the epithelium and the bowman layer
Epithelial Basement Membrane Dystrophy
Although several large pedigrees have been described in which patients affected with recurrent corneal erosions demonstrated characteristic clinical features of the dominantly inherited disorder of epithelial basement membrane dystrophy (EBMD; Mendelian Inheritance in Man [MIM] No. 121820), this condition has not been associated with a particular chromosomal locus because linkage analysis has not been performed in these or in other families. Difficulties in identifying the genetic basis of EBMD have arisen from difficulties encountered in defining the affected phenotype because affected patients may be asymptomatic,the often subtle epithelial changes are evanescent in nature, and the estimated phenocopy rate (ie, the number of other disorders of the corneal epithelium and the Bowman layer that may be associated with similar clinical features)is relatively high. However, the identification of the genetic basis of EBMD would be of interest to vision science researchers and refractive surgeons alike because the presence of subclinical EBMD is often associated with the development of a corneal epithelial defect during laser in situ keratomileusis,resulting in an increased risk of developing a number of different complications.Although screening of all individuals undergoing laser in situ keratomileusis,the most commonly performed surgical procedure in the United States, may not be practical, certainly, screening of family members of affected individuals who are interested in the procedure may be of benefit.
Meesmann Corneal Dystrophy
Meesmann corneal dystrophy (MIM No. 122100) is a dominantly inherited disorder of the corneal epithelium associated with the development of myriad epithelial microcysts in the first decade of life. Patients may remain asymptomatic for years, until epithelial erosions associated with rupture of the microcysts produce symptoms such as impaired visual acuity, pain, and photophobia. Meesmann corneal dystrophy is associated with mutations in the genes encoding 2 cornea-specific keratins, K3 (KRT3) and K12 (KRT12).18-27 With a single exception, all causative mutations reported to date have been missense substitutions in the highly conserved helix initiation motif found in exon 1 of KRT12 or in the helix termination motifs found in exon 7 of KRT3 and exon 6 of KRT1218-27 (Table 3).
Band-Shaped, Whorled Microcystic Corneal Dystrophy
Band-shaped, whorled microcystic corneal dystrophy (Lisch dystrophy)is unusual in that it is 1 of only 3 corneal dystrophies to have been linked to the X chromosome.28 Linkage analysis performed in a single affected family excluded linkage to the KRT3 and KRT12 loci and mapped the disease gene to the short arm of the X chromosome (Xp22.3).28 Affected patients demonstrate bilateral gray intraepithelial opacifications in band-shaped,spokelike, and whorled configurations that appear as epithelial microcysts on retroillumination. Affected patients may experience reduced visual acuity when the central cornea is involved, but recurrent epithelial erosions have not been reported.28-32
Reis33 published a report in 1917 of a dominantly inherited condition associated with recurrent corneal erosions and superficial corneal scarring occurring in the first 2 decades of life.More than 30 years later, Bücklers34 described a similar condition, found in members of the same family described by Reis.33 The clinical characteristics of what has become known as Reis-Bücklers dystrophy are similar to those of another dystrophy of the Bowman layer that was described by Thiel and Behnke35 in 1967. This has unfortunately led to confusion in the literature, which prompted Küchle et al36 to propose that classification be based not only on the clinical manifestations but also on the distinctive electron microscopic features of each. Küchle et al36 have proposed the terms corneal dystrophy of the Bowman layer type I (CDB I) (MIM No. 608470)for what had been previously known as Reis-Bücklers dystrophy or a superficial variant of granular dystrophy, and corneal dystrophy of the Bowman layer type II (CDB II) (MIM No. 602082) for what had been previously known as Thiel-Behnke or honeycomb-shaped dystrophy. As will be discussed in more detail in the section on the stromal dystrophies, the dominantly inherited CDB I and CDB II are associated with the Arg124Leu and Arg555Gln mutations, respectively,in the TGFBI gene.37 Screening of TGFBI in patients with Bowman layer dystrophies has demonstrated that most of the reported cases of CDB I are actually descriptions of CDB II, which appears to be much more common than CDB I.36 Although most of the individuals reported as having a Bowman layer dystrophy in whom TGFBI screening has been performed demonstrate one of the aforementioned mutations, a similar phenotype has been reported with other TGFBI mutations. In addition, 2 cases have been reported of individuals with CDB I in whom the classic Arg124Leu mutation was identified,but whose parents were unaffected.3 Because confirmatory maternity and paternity testing was performed in each case, these represent the first reports of spontaneous pathogenic mutations in TGFBI. These cases also highlight the clinical utility of molecular genetic analysis in confirming the diagnosis of a suspected corneal dystrophy,which was questioned, given the absence of a family history in each case.
A second genetic locus on chromosome 10 (10q23-q24) has been reported for the Bowman layer dystrophies, although linkage has been demonstrated in only 1 family to date.38-40
Dystrophies of the corneal stroma
The demonstration of linkage of lattice (LCD1) (MIM No. 122200), granular (GCD) (MIM No. 121900), and combined granular-lattice (CGLCD) (MIM No. 607541)corneal dystrophies to chromosome 5q31 by Stone and colleagues41 in 1994, followed 3 years later by the demonstration of pathogenic mutations in TGFBI in each of these dystrophies and in CDB I,42 ushered in a new era of understanding of the relationship between the various corneal dystrophies. Because each of the TGFBI dystrophies is most commonly associated with a mutation in 1of only 2 codons in TGFBI (Table 2), screening of these 2 codons will detect most of the pathogenic mutations in TGFBI. However, a large number of TGFBI mutations have been subsequently described in patients with a variety of phenotypes, most commonly as variants of LCD (Table 4).
Rather than create a new type of LCD, GCD, and CGLCD with the discovery of each novel mutation, it is simple and useful to classify the TGFBI dystrophies as classic and variant. Using this classification system, CDB, LCD, GCD, and CGLCD are diagnosed as they have been traditionally, ie, based on the clinical and histologic features. Molecular genetic analysis would be used to determine whether the dystrophy was classic, that is, associated with the most commonly identified mutations given in Table 2,or variant, that is, associated with 1 of the less commonly encountered mutations given in Table 4 or a novel mutation.Even with the aggregation of all of the variant forms of GCD, LCD, and CGLCD into a single category, most of the patients with a TGFBI dystrophy will still demonstrate one of the classic mutations.
Macular Corneal Dystrophy
In 2000, Akama and colleagues77 reported the identification of mutations in a newly recognized carbohydrate sulfotransferase gene (CHST6) on chromosome 16 (16q22) in patients with macular corneal dystrophy (MCD; MIM No. 217800). Corneal N-acetylglucosamine-6-sulfotransferase, the product of the CHST6 gene, has been demonstrated to catalyze the sulfation of N-acetylglucosamine in keratan sulfate, and identified mutations have been shown to result in a loss of enzymatic activity.78 This loss of activity in turn is thought to result in the formation of unsulfated keratan sulfate, leading to a loss of transparency in the corneas of affected patients. Akama and colleagues,77 as well as our group and others,79-91 have described coding region mutations in CHST6 in patients with type I MCD (differentiation between types I and IA was not performed),as well as deletions and rearrangements 5′ of CHST6 in patients with type II MCD. Although more than 100 mutations have been reported in CHST6 in individuals from a number of different ethnic groups, including patients with types I and II MCD, no association between the type and location of the mutation and the clinical features has been observed.77,79-91 This is in contrast to the TGFBI dystrophies, in which such a phenotype-genotype correlation is observed, and indicates that diagnostic mutation screening necessitates screening the entire CHST6 coding region because no mutation hot spots such as those noted in TGFBI, have been observed.
Central Crystalline Dystrophy of Schnyder
Wilbaut and Van Went92 published a description of the dominantly inherited central crystalline dystrophy of Schnyder (SCCD)(MIM No. 121800) in 1924 that today bears the name of the man who further described its characteristic clinical features in 2 studies published in 1929and 1939.93,94 An important distinguishing feature of SCCD is that it is associated with a number of nonocular manifestations,the most important of which is hypercholesterolemia, found in approximately 40% of affected patients.14 Cultured fibroblasts obtained from skin biopsy specimens demonstrate evidence of abnormal intracellular cholesterol metabolism, providing evidence of a generalized metabolic disorder and a means of confirming the diagnosis.95
Ten years ago, Shearman and colleagues96 mapped the genetic locus for SCCD in 2 large Swedish-Finnish families to the short arm of chromosome 1 (originally reported to be 1p34.1-1p36, but revised to 1p36.2-1p36.3). After performing fine mapping in these and an additional 11families, the authors refined the candidate interval to a 2.32-megabase region that contains 30 genes, including 24 genes with a known gene function (http://www.ncbi.nlm.nih.gov; build 36.1). However, our laboratory has recently completed screening the coding region of each of these positional candidate genes in 2 families with SCCD and has not identified a presumed pathogenic coding region mutation.97 The possibility remains that the genetic basis of SCCD in the families that we screened links to another chromosomal region (ie, locus heterogeneity exists for SCCD), that pathogenic mutations are present in the promoter region or the 5′ or 3′ untranslated region of one of the positional candidate genes, or that an unidentified gene within the candidate interval is involved.
The genetic basis of rare, dominantly inherited, visually insignificant Fleck corneal dystrophy (MIM No. 121850) was recently elucidated with the identification of pathogenic mutations in the PIP5K3 gene in affected individuals from 8 families.98 This gene is a member of the phosphoinositide 3–kinase family and is involved in generating and relaying phosphorylation signals that regulate the formation and localization of intracellular lipid products.98,99 Fleck corneal dystrophy is characterized by discrete gray-white stromal flecks,representing keratocytes containing excess glycosaminoglycan and lipids100-103 and is not associated with any systemic disorders involving mucopolysaccharide or lipid deposition.
Congenital Hereditary Stromal Dystrophy
Congenital hereditary stromal dystrophy (MIM No. 610048), an uncommon cause of congenital corneal opacification, has been reported in only 4 families in the English-language ophthalmic literature since it was first described in 1939.104-107 In 2005, Bredrup and colleagues105 reported a mutation in the decorin gene in a newly described pedigree with congenital hereditary stromal dystrophy. Those authors hypothesized that the identified frameshift mutation in the decorin gene results in premature truncation of the protein product, a dermatan sulfate proteoglycan. This in turn results in abnormal binding of the mutant protein to collagen, disrupting collagen fibril spacing and thereby resulting in loss of corneal clarity.105
Dystrophies of the descemet membrane and endothelium
Fuchs Endothelial Corneal Dystrophy
In 2001, Biswas and colleagues108 reported the results of a genome-wide linkage analysis in a large family with early-onset Fuchs endothelial corneal dystrophy (FECD) (MIM No. 136800), demonstrating linkage to a 6- to 7-centimorgan region on chromosome 1p34.3-1p32. The gene that encodes the α2 chain of type VIII collagen, COL8A2, was previously mapped to this region109 and was selected for screening because it is highly expressed in the Descemet membrane.110 A missense mutation, Gln455Lys,was identified that segregated with the disease in the family.108 Gottsch and colleagues111 have also identified a missense mutation, Leu450Trp, in another family with early-onset FECD, indicating that mutations in COL8A2 are associated with an early-onset variant of FECD.
Although 3 other presumed pathogenic COL8A2 sequence variants were identified by Biswas and colleagues108 in families with classic late-onset FECD, the identification of 2 of these variants in unaffected control individuals112,113 and the identification of the third variant in only a single sporadic case of FECD of more than 200 unrelated affected individuals screened indicates that it is likely a rare polymorphism.108,112,113 Thus,insufficient evidence exists to implicate COL8A2 mutations in the pathogenesis of classic FECD.
Several genome-wide linkage studies performed recently in families with the classic late-onset form of FECD have demonstrated evidence of linkage to a number of different chromosomal regions. Sundin and colleagues114 have demonstrated linkage to a 26.4-megabase region on chromosome 13 (13pTel-13q12.13) in a large kindred with FECD, although screening of the positional candidate genes has not identified any presumed pathogenic mutations. Recently, Sundin and colleagues115 reported linkage of 3 unrelated families with FECD to a 6.9-megabase region on chromosome 18 (18q21.2-18q21.32), although no pathogenic mutations have been identified in the positional candidate genes screened to date. Thus, it appears that locus heterogeneity may exist for FECD, in which mutations in several genes on different chromosomes may produce a common disease phenotype.
A National Institutes of Health–sponsored multicenter study to identify the genetic basis of classic FECD, organized in 2005 by investigators at Case Western Reserve University, Cleveland, Ohio, is currently recruiting affected families with the goal of enrolling 500 families from the 24 study sites. Given the delayed onset of the affected phenotype in FECD, single families with classic FECD typically do not have a sufficient number of individuals in multiple generations to successfully perform genome-wide association studies.Therefore, this multicenter study is recruiting hundreds of affected sibling pairs for use in performing genome-wide linkage analysis, which may replicate linkage to a previously identified locus for FECD or demonstrate linkage to other chromosomal loci.
Congenital Hereditary Endothelial Dystrophies
Congenital hereditary endothelial dystrophy (CHED) (MIM No. 121700)is a rare, dominantly inherited cause of congenital corneal opacification.Autosomal dominant (CHED1) and autosomal recessive (CHED2) forms of CHED have been described, differing in the time of onset and characteristic clinical features. Both forms have been mapped to genetically distinct loci on chromosome 20, with CHED1 having been mapped to a region that lies within the region linked to posterior polymorphous dystrophy,116-119 features of which are noted with increased frequency in relatives of patients with the dominant form of CHED. Recently, Vithana and colleagues120 have reported that mutations in the SLC4A11 gene, a member of the SLC4 family of bicarbonate transporter proteins, are associated with CHED2; missense and nonsense mutations in this gene segregated with the disease phenotype in 8 affected pedigrees.
Posterior Polymorphous Corneal Dystrophy
Although mutations in the visual system homeobox gene 1 (VSX1) (MIM No. 605020), COL8A2, and the gene for transcription factor 8 (TCF8) have been reported to play a role in the pathogenesis of posterior polymorphous corneal dystrophy (PPCD) (MIM No. 122000), convincing evidence exists to support the role of only TCF8 mutations in this autosomal dominant corneal endothelial dystrophy. In 1995, Heon and colleagues121 reported the results of a genome-wide linkage analysis in a large family with PPCD,demonstrating evidence of linkage to the long arm of chromosome 20 (20q11).The VSX1 gene was mapped to the PPCD candidate interval in 2000 and was selected for screening by Heon and colleagues122 2years later as a positional and functional candidate gene for PPCD because it is a homeodomain-containing transcription factor gene that regulates the expression of cellular differentiation during development in various tissues,including the eye.123 Although 2 presumed pathogenic mutations were identified (Asp144Glu and Gly160Asp), our laboratory's identification of the Asp144Glu missense change in an unaffected control subject and the identification of the Gly160Asp variant in individuals without PPCD and in only 1 of 49 affected probands in whom VSX1 screening has been reported have led to doubts about a potential role of VSX1 in the pathogenesis of PPCD.13,122,124-126
After the identification of COL8A2 mutations in families with FECD, Biswas and colleagues108 screened COL8A2 in 15 patients with PPCD, assuming that the 2 endothelial dystrophies might share a common genetic basis. Although a presumed pathogenic mutation was identified in 2 related individuals, our laboratory and others have not identified this previously reported mutation or any novel presumed pathogenic mutations in COL8A2 in a large number of individuals affected with PPCD, raising questions regarding the role of COL8A2 in PPCD.13,112,127
Krafchak and colleagues13 have recently reported frameshift and nonsense mutations in TCF8 in 5 of 11 families with PPCD. Each mutation was demonstrated to segregate with the affected phenotype in each family examined with the exception of 2 unaffected individuals from 1 large family. This exception was attributed by the authors to incomplete penetrance. Our laboratory has also identified presumed pathogenic frameshift and nonsense mutations in TCF8 in 25%of the affected probands screened; each TCF8 mutation identified by Krafchak et al13 and our laboratory has been identified in only a single family. Although the mechanism by which TCF8 mutations result in the ocular and histopathologic findings associated with PPCD (characterized by abnormal epithelial cell–like corneal endothelial cells128,129)has not been clearly elucidated, TCF8 has been demonstrated to be involved in the repression of the epithelial cell phenotype.130,131
X-Linked Endothelial Corneal Dystrophy
The most recently described corneal dystrophy, X-linked endothelial corneal dystrophy (XECD), has been identified in a single large Austrian pedigree in which an X-linked inheritance pattern is suggested by the transmission of the dystrophy from affected fathers to all of their daughters but to none of their sons.132 However, the corneal endothelial changes, described as resembling moon craters, were observed in both male and female patients. Corneal opacification, in the form of congenital corneal edema and subepithelial band keratopathy, was identified only in male patients,however.132 To identify the genetic basis of XECD, the authors performed linkage analysis of the X chromosome and demonstrated evidence of linkage to a 4.73-centimorgan region on Xq25. Because this candidate gene region contains less than 100 known and predicted genes, the authors are in the process of prioritizing and screening the positional candidate genes.132
Identification of the genetic basis of many of the corneal dystrophies has led to the identification and characterization of many of the encoded proteins responsible for maintaining corneal transparency and thus has opened many new avenues of investigation for vision scientists. Clinicians have also benefited from the ability to definitively differentiate between dystrophic and nondystrophic causes of corneal opacification1,2,5,133,134 and will continue to use molecular diagnostic testing with increasing frequency in their practices as the genetic basis of more of the corneal dystrophies is elucidated and efficient screening methods for the most common pathogenic mutations continue to be refined. Diagnostic laboratories such as The John and Marcia Carver Nonprofit Genetic Testing Laboratory at the University of Iowa, Iowa City (http://www.carverlab.org) already offer clinicians the ability to screen for mutations in genes associated with a variety of inherited ocular disorders, including the TGBFI dystrophies. As mentioned previously, the TGBFI gene is ideally suited for mutation screening because most of the pathogenic mutations occur at 1 of 2 mutation hot spots (Table 2). Commercially available buccal swabs and saliva specimen containers that greatly simplify the collection, packaging, and shipping of DNA specimens for analysis also have eliminated nearly all of the practical constraints that a clinician might encounter in relying on peripheral blood specimens as a source of DNA for genetic analysis.1,2
Beyond providing the clinician with a definitive diagnostic tool, elucidation of the molecular genetic basis of the corneal dystrophies also has led to the ability to develop animal models of corneal disorders,135-138 the next step in developing and testing novel treatment strategies for the corneal dystrophies.139
Correspondence: Anthony J. Aldave, MD, Jules Stein Eye Institute, 100 Stein Plaza, University of California–Los Angeles,Los Angeles, CA 90095 (aldave@jsei.ucla.edu).
Submitted for Publication: June 13, 2006; final revision received August 26, 2006; accepted August 28, 2006.
Financial Disclosure: None reported.
1.Aldave
AJYellore
VSSelf
CAHolsclaw
DSmall
K The usefulness of buccal swabs for mutation screening in patients with suspected corneal dystrophies.
Ophthalmology 2004;1111407- 1409
PubMedGoogle Scholar 2.Aldave
AJ The clinical utility of genetic analysis in the diagnosis and management of inherited corneal disorders.
Contemp Ophthalmol 2005;41- 10
Google Scholar 3.Tanhehco
TYEifrig
DE
JrSchwab
IRRapuano
CJKlintworth
GK Two cases of Reis-Bucklers corneal dystrophy (granular corneal dystrophy type III) caused by spontaneous mutations in the
TGFBI gene.
Arch Ophthalmol 2006;124589- 593
PubMedGoogle Scholar 4.Aldave
AJGutmark
JGYellore
VS
et al. Lattice corneal dystrophy associated with the Ala546Asp and Pro551Gln missense changes in the TGFBI gene.
Am J Ophthalmol 2004;138772- 781
PubMedGoogle Scholar 5.Aldave
AJRayner
SAKing
JAAffeldt
JAYellore
VS A unique corneal dystrophy of Bowman's layer and stroma associated with the Gly623Asp mutation in the transforming growth factor beta–induced (TGFBI) gene.
Ophthalmology 2005;1121017- 1022
PubMedGoogle Scholar 6.Klintworth
GKBao
WAfshari
NA Two mutations in the TGFBI (BIGH3) gene associated with lattice corneal dystrophy in an extensively studied family.
Invest Ophthalmol Vis Sci 2004;451382- 1388
PubMedGoogle Scholar 7.Aldave
AJRayner
SAKim
BTPrechanond
AYellore
VS Unilateral lattice corneal dystrophy associated with the novel His572del mutation in the TGFBI gene.
Mol Vis 2006;12142- 146
PubMedGoogle Scholar 8.Hirano
KHotta
YNakamura
MFujiki
KKanai
AYamamoto
N Late-onset form of lattice corneal dystrophy caused by leu527Arg mutation of the TGFBI gene.
Cornea 2001;20525- 529
PubMedGoogle Scholar 9.Sridhar
MSLaibson
PREagle
RC
JrRapuano
CJCohen
EJ Unilateral corneal lattice dystrophy.
Cornea 2001;20850- 852
PubMedGoogle Scholar 10.Sridhar
MSPandrowala
HRao
GN Unilateral lattice dystrophy in an elderly patient.
Eye 2002;16653- 655
PubMedGoogle Scholar 11.Stewart
HBlack
GCDonnai
D
et al. A mutation within exon 14 of the TGFBI (BIGH3) gene on chromosome 5q31causes an asymmetric, late-onset form of lattice corneal dystrophy.
Ophthalmology 1999;106964- 970
PubMedGoogle Scholar 12.Klintworth
GKVogel
FS Macular corneal dystrophy: an inherited acid mucopolysaccharide storage disease of the corneal fibroblast.
Am J Pathol 1964;45565- 586
PubMedGoogle Scholar 13.Krafchak
CMPawar
HMoroi
SE
et al. Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells.
Am J Hum Genet 2005;77694- 708
PubMedGoogle Scholar 14.Bron
AJWilliams
HPCarruthers
ME Hereditary crystalline stromal dystrophy of Schnyder, I: clinical features of a family with hyperlipoproteinaemia.
Br J Ophthalmol 1972;56383- 399
PubMedGoogle Scholar 15.Ridgway
AEAkhtar
SMunier
FL
et al. Ultrastructural and molecular analysis of Bowman's layer corneal dystrophies:an epithelial origin?
Invest Ophthalmol Vis Sci 2000;413286- 3292
PubMedGoogle Scholar 16.Akhtar
SMeek
KMRidgway
AEBonshek
REBron
AJ Deposits and proteoglycan changes in primary and recurrent granular dystrophy of the cornea.
Arch Ophthalmol 1999;117310- 321
PubMedGoogle Scholar 17.Johnson
BLBrown
SIZaidman
GW A light and electron microscopic study of recurrent granular dystrophy of the cornea.
Am J Ophthalmol 1981;9249- 58
PubMedGoogle Scholar 18.Coleman
CMHannush
SCovello
SPSmith
FJUitto
JMcLean
WH A novel mutation in the helix termination motif of keratin K12 in a US family with Meesmann corneal dystrophy.
Am J Ophthalmol 1999;128687- 691
PubMedGoogle Scholar 19.Corden
LDSwensson
OSwensson
B
et al. A novel keratin 12 mutation in a German kindred with Meesmann's corneal dystrophy.
Br J Ophthalmol 2000;84527- 530
PubMedGoogle Scholar 20.Corden
LDSwensson
OSwensson
B
et al. Molecular genetics of Meesmann's corneal dystrophy: ancestral and novel mutations in keratin 12 (K12) and complete sequence of the human KRT12 gene.
Exp Eye Res 2000;7041- 49
PubMedGoogle Scholar 21.Irvine
ADColeman
CMMoore
JE
et al. A novel mutation in
KRT12 associated with Meesmann's epithelial corneal dystrophy.
Br J Ophthalmol 2002;86729- 732
PubMedGoogle Scholar 22.Irvine
ADCorden
LDSwensson
O
et al. Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy.
Nat Genet 1997;16184- 187
PubMedGoogle Scholar 23.Nishida
KHonma
YDota
A
et al. Isolation and chromosomal localization of a cornea-specific human keratin 12 gene and detection of four mutations in Meesmann corneal epithelial dystrophy.
Am J Hum Genet 1997;611268- 1275
PubMedGoogle Scholar 24.Takahashi
KMurakami
AOkisaka
SKimura
TKanai
A Heterozygous Ala137Pro mutation in keratin 12 gene found in Japanese with Meesmann's corneal dystrophy.
Jpn J Ophthalmol 2002;46673- 674
PubMedGoogle Scholar 25.Nichini
OManzi
VMunier
FLSchorderet
DF Meesmann corneal dystrophy (MECD): report of 2 families and a novel mutation in the cornea specific keratin 12 (
KRT12)gene.
Ophthalmic Genet 2005;26169- 173
PubMedGoogle Scholar 26.Chen
YTTseng
SHChao
SC Novel mutations in the helix termination motif of keratin 3 and keratin 12 in 2 Taiwanese families with Meesmann corneal dystrophy.
Cornea 2005;24928- 932
PubMedGoogle Scholar 27.Yoon
MKWarren
JFHolsclaw
DSGritz
DCMargolis
TP A novel arginine substitution mutation in 1A domain and a novel 27bp insertion mutation in 2B domain of keratin 12 gene associated with Meesmann's corneal dystrophy.
Br J Ophthalmol 2004;88752- 756
PubMedGoogle Scholar 28.Lisch
WButtner
AOeffner
F
et al. Lisch corneal dystrophy is genetically distinct from Meesmann corneal dystrophy and maps to xp22.3.
Am J Ophthalmol 2000;130461- 468
PubMedGoogle Scholar 29.Lisch
WSteuhl
KPLisch
C
et al. A new, band-shaped and whorled microcystic dystrophy of the corneal epithelium.
Am J Ophthalmol 1992;11435- 44
PubMedGoogle Scholar 31.Charles
NCYoung
JAKumar
A
et al. Band-shaped and whorled microcystic dystrophy of the corneal epithelium.
Ophthalmology 2000;1071761- 1764
PubMedGoogle Scholar 32.Robin
SBEpstein
RJKornmehl
EW Band-shaped, whorled microcystic corneal dystrophy.
Am J Ophthalmol 1994;117543- 544
PubMedGoogle Scholar 33.Reis
W Familiare, fleckige Hornhautentartung.
Dtsch Med Wochenschr 1917;43575
Google Scholar 34.Bücklers
M Uber eine weitere familiare Hornhaut dystrophie (Reis).
Klin Monatsbl Augenheilkd 1949;114386- 397
Google Scholar 35.Thiel
HJBehnke
H Eine bisher unbekannte, subepitheliale hereditare Hornhaut-dystrophie.
Klin Monatsbl Augenheilkd 1967;150862- 874
PubMedGoogle Scholar 36.Küchle
MGreen
WRVolcker
HEBarraquer
J Reevaluation of corneal dystrophies of Bowman's layer and the anterior stroma (Reis-Bucklers and Thiel-Behnke types): a light and electron microscopic study of eight corneas and a review of the literature.
Cornea 1995;14333- 354
PubMedGoogle Scholar 37.Okada
MYamamoto
STsujikawa
M
et al. Two distinct kerato-epithelin mutations in Reis-Bucklers corneal dystrophy.
Am J Ophthalmol 1998;126535- 542
PubMedGoogle Scholar 38.Sorour
HMYee
SBPeterson
NJ
et al. Recurrence of chromosome 10 Thiel-Behnke corneal dystrophy (CDB2) after excimer laser phototherapeutic keratectomy or penetrating keratoplasty.
Cornea 2005;2445- 50
PubMedGoogle Scholar 39.Sullivan
LSZhao
XBowne
SJ
et al. Exclusion of the human collagen type XVII (
COL17A1) gene as the cause of Thiel-Behnke corneal dystrophy (
CDB2) on chromosome 10q23-q25.
Curr Eye Res 2003;27223- 226
PubMedGoogle Scholar 40.Yee
RWSullivan
LSLai
HT
et al. Linkage mapping of Thiel-Behnke corneal dystrophy (CDB2) to chromosome 10q23-q24.
Genomics 1997;46152- 154
PubMedGoogle Scholar 41.Stone
EMMathers
WDRosenwasser
GO
et al. Three autosomal dominant corneal dystrophies map to chromosome 5q.
Nat Genet 1994;647- 51
PubMedGoogle Scholar 42.Munier
FLKorvatska
EDjemai
A
et al. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies.
Nat Genet 1997;15247- 251
PubMedGoogle Scholar 43.Ha
NTCung le
XChau
HM
et al. A novel mutation of the TGFBI gene found in a Vietnamese family with atypical granular corneal dystrophy.
Jpn J Ophthalmol 2003;47246- 248
PubMedGoogle Scholar 44.Cung le
XHa
NTChau
HM
et al. Mutation analysis of the TGFBI gene in Vietnamese with granular and Avellino corneal dystrophy.
Jpn J Ophthalmol 2004;4812- 16
PubMedGoogle Scholar 45.Munier
FLFrueh
BEOthenin-Girard
P
et al. BIGH3 mutation spectrum in corneal dystrophies.
Invest Ophthalmol Vis Sci 2002;43949- 954
PubMedGoogle Scholar 46.Stewart
HSRidgway
AEDixon
MJBonshek
RParveen
RBlack
G Heterogeneity in granular corneal dystrophy: identification of three causative mutations in the TGFBI (
BIGH3) gene: lessons for corneal amyloidogenesis.
Hum Mutat 1999;14126- 132
PubMedGoogle Scholar 47.Dighiero
PNiel
FEllies
P
et al. Histologic phenotype-genotype correlation of corneal dystrophies associated with eight distinct mutations in the
TGFBI gene.
Ophthalmology 2001;108818- 823
PubMedGoogle Scholar 48.Dighiero
PDrunat
SD’Hermies
FRenard
GDelpech
MValleix
S A novel variant of granular corneal dystrophy caused by association of 2 mutations in the
TGFBI gene—R124L and ΔT125-ΔE126.
Arch Ophthalmol 2000;118814- 818
PubMedGoogle Scholar 50.Mashima
YYamamoto
SInoue
Y
et al. Association of autosomal dominantly inherited corneal dystrophies with
BIGH3 gene mutations in Japan.
Am J Ophthalmol 2000;130516- 517
PubMedGoogle Scholar 51.Ha
NTFujiki
KHotta
YNakayasu
KKanai
A Q118X mutation of
M1S1 gene caused gelatinous drop-like corneal dystrophy: the P501T of
BIGH3 gene found in a family with gelatinous drop-like corneal dystrophy.
Am J Ophthalmol 2000;130119- 120
PubMedGoogle Scholar 52.Kawasaki
SNishida
KQuantock
AJDota
ABennett
KKinoshita
S Amyloid and Pro501 Thr-mutated βig-h3 gene product colocalize in lattice corneal dystrophy type IIIA.
Am J Ophthalmol 1999;127456- 458
PubMedGoogle Scholar 53.Tsujikawa
KTsujikawa
MYamamoto
SFujikado
TTano
Y Allelic homogeneity due to a founder mutation in Japanese patients with lattice corneal dystrophy type IIIA.
Am J Med Genet 2002;11320- 22
PubMedGoogle Scholar 54.Yamamoto
SOkada
MTsujikawa
M
et al. A kerato-epithelin (βig-h3) mutation in lattice corneal dystrophy type IIIA.
Am J Hum Genet 1998;62719- 722
PubMedGoogle Scholar 55.Tian
XFujiki
KWang
W
et al. Novel mutation (V505D) of the TGFBI gene found in a Chinese family with lattice corneal dystrophy, type I.
Jpn J Ophthalmol 2005;4984- 88
PubMedGoogle Scholar 56.Fujiki
KHotta
YNakayasu
K
et al. Six different mutations of TGFBI (βig-h3, keratoepithelin) gene found in Japanese corneal dystrophies.
Cornea 2000;19842- 845
PubMedGoogle Scholar 57.Hirano
KNakamura
MYamamoto
NHotta
Y Geographical feature of lattice corneal dystrophy patients in Aichi Prefecture: an analysis of the TGFBI gene [in Japanese].
Nippon Ganka Gakkai Zasshi 2002;106352- 359
PubMedGoogle Scholar 58.Endo
SNguyen
THFujiki
K
et al. Leu518Pro mutation of the βig-h3 gene causes lattice corneal dystrophy type I.
Am J Ophthalmol 1999;128104- 106
PubMedGoogle Scholar 59.Hirano
KHotta
YFujiki
KKanai
A Corneal amyloidosis caused by Leu518Pro mutation of βig-h3 gene.
Br J Ophthalmol 2000;84583- 585
PubMedGoogle Scholar 60.Fujiki
KHotta
YNakayasu
K
et al. A new L527R mutation of the βig-h3 gene in patients with lattice corneal dystrophy with deep stromal opacities.
Hum Genet 1998;103286- 289
PubMedGoogle Scholar 61.Funayama
TMashima
YKawashima
MYamada
M Lattice corneal dystrophy type III in patients with a homozygous L527R mutation in the
TGFBI gene.
Jpn J Ophthalmol 2006;5062- 64
PubMedGoogle Scholar 62.Kawashima
MYamada
MFunayama
TMashima
Y Six cases of late-onset lattice corneal dystrophy associated with gene mutations induced by the transforming growth factor-beta [in Japanese].
Nippon Ganka Gakkai Zasshi 2005;10993- 100
PubMedGoogle Scholar 63.Nakagawa
ESakimoto
TInada
N
et al. Histopathological study of lattice corneal dystrophy with L527R mutation of transforming growth factor-β induced gene [in Japanese].
Nippon Ganka Gakkai Zasshi 2004;108118- 123
PubMedGoogle Scholar 64.Yamada
NChikama
TIMorishige
N
et al. Homozygous mutation (L527R) of TGFBI in an individual with lattice corneal dystrophy.
Br J Ophthalmol 2005;89771- 773
PubMedGoogle Scholar 65.Chakravarthi
SVKannabiran
CSridhar
MSVemuganti
GK TGFBI gene mutations causing lattice and granular corneal dystrophies in Indian patients.
Invest Ophthalmol Vis Sci 2005;46121- 125
PubMedGoogle Scholar 66.Rozzo
CFossarello
MGalleri
G
et al. A common beta ig-h3 gene mutation (delta f540) in a large cohort of Sardinian Reis Bucklers corneal dystrophy patients: mutations in brief No.180: online.
Hum Mutat 1998;12215- 216
PubMedGoogle Scholar 67.Stix
BLeber
MBingemer
P
et al. Hereditary lattice corneal dystrophy is associated with corneal amyloid deposits enclosing C-terminal fragments of keratoepithelin.
Invest Ophthalmol Vis Sci 2005;461133- 1139
PubMedGoogle Scholar 68.Nakagawa Asahina
SFujiki
KEnomoto
YMurakami
AKanai
A Case of late onset and isolated lattice corneal dystrophy with Asn544Ser (N544S) mutation of transforming growth factor β–induced (TGFBI,BIGH3) gene [in Japanese].
Nippon Ganka Gakkai Zasshi 2004;108618- 620
PubMedGoogle Scholar 69.Solari
HPVentura
MPPerez
ABSallum
JMBurnier
MNBelfort
R TGFBI gene mutations in Brazilian patients with corneal dystrophy.
Eye 2006;[published online ahead of print January 27, 2006]June 13, 2006doi:10.1038/sj.eye.6702264.
Google Scholar 70.Dighiero
PDrunat
SEllies
P
et al. A new mutation (A546T) of the βig-h3 gene responsible for a French lattice corneal dystrophy type IIIA.
Am J Ophthalmol 2000;129248- 251
PubMedGoogle Scholar 71.Eifrig
DE
JrAfshari
NABuchanan
HWTBowling
BLKlintworth
GK Polymorphic corneal amyloidosis: a disorder due to a novel mutation in the transforming growth factor β–induced (BIGH3) gene.
Ophthalmology 2004;1111108- 1114
PubMedGoogle Scholar 72.Warren
JFAbbott
RLYoon
MKCrawford
JBSpencer
WHMargolis
TP A new mutation (Leu569Arg) within exon 13 of the TGFBI (
BIGH3) gene causes lattice corneal dystrophy type I.
Am J Ophthalmol 2003;136872- 878
PubMedGoogle Scholar 73.Afshari
NAMullally
JEAfshari
MA
et al. Survey of patients with granular, lattice, avellino, and Reis-Bucklers corneal dystrophies for mutations in the
BIGH3 and gelsolin genes.
Arch Ophthalmol 2001;11916- 22
PubMedGoogle Scholar 74.Afshari
NBahadur
RPKlintworth
GK Discovery of novel homozygous mutation in the TGFBI (BIGH3) gene (V624M)in a patient with unilateral lattice corneal dystrophy.
Invest Ophthalmol Vis Sci 2004;45E-abstract 1517
Google Scholar 75.Chau
HMHa
NTCung
LX
et al. H626R and R124C mutations of the TGFBI (
BIGH3)gene caused lattice corneal dystrophy in Vietnamese people.
Br J Ophthalmol 2003;87686- 689
PubMedGoogle Scholar 76.Schmitt-Bernard
CFGuittard
CArnaud
B
et al. BIGH3 exon 14 mutations lead to intermediate type I/IIIA of lattice corneal dystrophies.
Invest Ophthalmol Vis Sci 2000;411302- 1308
PubMedGoogle Scholar 77.Akama
TONishida
KNakayama
J
et al. Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene.
Nat Genet 2000;26237- 241
PubMedGoogle Scholar 78.Akama
TONakayama
JNishida
K
et al. Human corneal GlcNac 6-O-sulfotransferase and mouse intestinal GlcNac 6-O-sulfotransferase both produce keratan sulfate.
J Biol Chem 2001;27616271- 16278
PubMedGoogle Scholar 79.Abbruzzese
CKuhn
UMolina
FRama
PDe Luca
M Novel mutations in the
CHST6 gene causing macular corneal dystrophy.
Clin Genet 2004;65120- 125
PubMedGoogle Scholar 80.Aldave
AJYellore
VSThonar
EJ
et al. Novel mutations in the carbohydrate sulfotransferase gene (
CHST6) in American patients with macular corneal dystrophy.
Am J Ophthalmol 2004;137465- 473
PubMedGoogle Scholar 81.El-Ashry
MFAbd El-Aziz
MMShalaby
O
et al. Novel CHST6 nonsense and missense mutations responsible for macular corneal dystrophy.
Am J Ophthalmol 2005;139192- 193
PubMedGoogle Scholar 82.El-Ashry
MFEl-Aziz
MMWilkins
S
et al. Identification of novel mutations in the carbohydrate sulfotransferase gene (
CHST6) causing macular corneal dystrophy.
Invest Ophthalmol Vis Sci 2002;43377- 382
PubMedGoogle Scholar 83.Ha
NTChau
HMCung le
X
et al. Identification of novel mutations of the CHST6 gene in Vietnamese families affected with macular corneal dystrophy in two generations.
Cornea 2003;22508- 511
PubMedGoogle Scholar 84.Ha
NTChau
HMCung le
X
et al. Mutation analysis of the carbohydrate sulfotransferase gene in Vietnamese with macular corneal dystrophy.
Invest Ophthalmol Vis Sci 2003;443310- 3316
PubMedGoogle Scholar 85.Iida-Hasegawa
NFuruhata
AHayatsu
H
et al. Mutations in the CHST6 gene in patients with macular corneal dystrophy:immunohistochemical evidence of heterogeneity.
Invest Ophthalmol Vis Sci 2003;443272- 3277
PubMedGoogle Scholar 86.Liu
NPBao
WSmith
CFVance
JMKlintworth
GK Different mutations in carbohydrate sulfotransferase 6 (
CHST6) gene cause macular corneal dystrophy types I and II in a single sibship.
Am J Ophthalmol 2005;1391118- 1120
PubMedGoogle Scholar 87.Liu
NPDew-Knight
SRayner
M
et al. Mutations in corneal carbohydrate sulfotransferase 6 gene (CHST6) cause macular corneal dystrophy in Iceland.
Mol Vis 2000;6261- 264
PubMedGoogle Scholar 88.Niel
FEllies
PDighiero
P
et al. Truncating mutations in the carbohydrate sulfotransferase 6 gene (
CHST6) result in macular corneal dystrophy.
Invest Ophthalmol Vis Sci 2003;442949- 2953
PubMedGoogle Scholar 89.Sultana
ASridhar
MSJagannathan
ABalasubramanian
DKannabiran
CKlintworth
GK Novel mutations of the carbohydrate sulfotransferase-6 (
CHST6) gene causing macular corneal dystrophy in India.
Mol Vis 2003;9730- 734
PubMedGoogle Scholar 90.Sultana
ASridhar
MSKlintworth
GKBalasubramanian
DKannabiran
C Allelic heterogeneity of the carbohydrate sulfotransferase-6 gene in patients with macular corneal dystrophy.
Clin Genet 2005;68454- 460
PubMedGoogle Scholar 91.Warren
JFAldave
AJSrinivasan
M
et al. Novel mutations in the
CHST6 gene associated with macular corneal dystrophy in southern India.
Arch Ophthalmol 2003;1211608- 1612
PubMedGoogle Scholar 92.Wilbaut
FVan Went
JM Een zeldzame erfelijke Hoornvliesaandoening.
Ned Tijdschr Geneeskd 1924;12996- 2997
Google Scholar 93.Schnyder
WF Scheibenförmige Kristalleinlagerungen in der Hornhautmitte als Erbleiden.
Klin Monatsbl Augenheilkd 1939;103494- 502
Google Scholar 94.Schnyder
WF Mitteilung über einen neuen Typus von familiärer Hornhauterkrankung.
Schweiz Med Wochenschr 1929;59559- 571
Google Scholar 95.Battisti
CDotti
MTMalandrini
APezzella
FBardelli
AMFederico
A Schnyder corneal crystalline dystrophy: description of a new family with evidence of abnormal lipid storage in skin fibroblasts.
Am J Med Genet 1998;7535- 39
PubMedGoogle Scholar 96.Shearman
AMHudson
TJAndresen
JM
et al. The gene for Schnyder's crystalline corneal dystrophy maps to human chromosome 1p34.1-p36.
Hum Mol Genet 1996;51667- 1672
PubMedGoogle Scholar 97.Aldave
AJRayner
SAPrincipe
AHAffeldt
JAKatsev
DYellore
VS Analysis of fifteen positional candidate genes for Schnyder crystalline corneal dystrophy.
Mol Vis 2005;11713- 716
PubMedGoogle Scholar 98.Li
STiab
LJiao
X
et al. Mutations in PIP5K3 are associated with Francois-Neetens mouchetee fleck corneal dystrophy.
Am J Hum Genet 2005;7754- 63
PubMedGoogle Scholar 99.Sbrissa
DIkonomov
OCShisheva
A PIKfyve lipid kinase is a protein kinase: downregulation of 5′-phosphoinositide product formation by autophosphorylation.
Biochemistry 2000;3915980- 15989
PubMedGoogle Scholar 101.Holopainen
JMMoilanen
JATervo
TM In vivo confocal microscopy of Fleck dystrophy and pre-Descemet's membrane corneal dystrophy.
Cornea 2003;22160- 163
PubMedGoogle Scholar 103.Nicholson
DHGreen
WRCross
HEKenyon
KRMassof
D A clinical and histopathological study of Francois-Neetens speckled corneal dystrophy.
Am J Ophthalmol 1977;83554- 560
PubMedGoogle Scholar 104.Turpin
RTisserand
MSerane
J Opacites corneennes hereditaires et congenitales reparties sur trois generations et atteignant deux jumelles monozygotes.
Arch Ophthalmol (Paris) 1939;3109- 111
Google Scholar 105.Bredrup
CKnappskog
PMMajewski
JRodahl
EBoman
H Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene.
Invest Ophthalmol Vis Sci 2005;46420- 426
PubMedGoogle Scholar 106.Van Ginderdeuren
RDe Vos
RCasteels
IFoets
B Report of a new family with dominant congenital heredity stromal dystrophy of the cornea.
Cornea 2002;21118- 120
PubMedGoogle Scholar 107.Witschel
HFine
BSGrutzner
PMcTigue
JW Congenital hereditary stromal dystrophy of the cornea.
Arch Ophthalmol 1978;961043- 1051
PubMedGoogle Scholar 108.Biswas
SMunier
FLYardley
J
et al. Missense mutations in COL8A2, the gene encoding the α2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy.
Hum Mol Genet 2001;102415- 2423
PubMedGoogle Scholar 109.Muragaki
YJacenko
OApte
SMattei
MGNinomiya
YOlsen
BR The alpha 2 (VIII) collagen gene: a novel member of the short chain collagen family located on the human chromosome 1.
J Biol Chem 1991;2667721- 7727
PubMedGoogle Scholar 110.Kapoor
RSakai
LYFunk
SRoux
EBornstein
PSage
EH Type VIII collagen has a restricted distribution in specialized extracellular matrices.
J Cell Biol 1988;107721- 730
PubMedGoogle Scholar 111.Gottsch
JDSundin
OHLiu
SH
et al. Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of Fuchs corneal dystrophy.
Invest Ophthalmol Vis Sci 2005;461934- 1939
PubMedGoogle Scholar 112.Kobayashi
AFujiki
KMurakami
A
et al. Analysis of COL8A2 gene mutation in Japanese patients with Fuchs' endothelial dystrophy and posterior polymorphous dystrophy.
Jpn J Ophthalmol 2004;48195- 198
PubMedGoogle Scholar 113.Aldave
AJRayner
SASalem
AK
et al. No pathogenic mutations identified in the COL8A1 and COL8A2 genes in familial Fuchs corneal dystrophy.
Invest Ophthalmol Vis Sci 2006;473787- 3790
PubMedGoogle Scholar 114.Sundin
OHJun
ASBroman
KW
et al. Linkage of late-onset Fuchs corneal dystrophy to a novel locus at 13pTel-13q12.13.
Invest Ophthalmol Vis Sci 2006;47140- 145
PubMedGoogle Scholar 115.Sundin
OHBroman
KWChang
HHStark
WJVito
ECGottsch
JD A common locus for late-onset Fuchs corneal dystrophy maps to 18q21.2-q21.32.
Invest Ophthalmol Vis Sci 2006;473919- 3926
PubMedGoogle Scholar 116.Kanis
ABAl-Rajhi
AATaylor
CM
et al. Exclusion of AR-CHED from the chromosome 20 region containing the PPMD and AD-CHED loci.
Ophthalmic Genet 1999;20243- 249
PubMedGoogle Scholar 117.Hand
CKHarmon
DLKennedy
SMFitzSimon
JSCollum
LMParfrey
NA Localization of the gene for autosomal recessive congenital hereditary endothelial dystrophy (CHED2) to chromosome 20 by homozygosity mapping.
Genomics 1999;611- 4
PubMedGoogle Scholar 118.Callaghan
MHand
CKKennedy
SMFitzSimon
JSCollum
LMParfrey
NA Homozygosity mapping and linkage analysis demonstrate that autosomal recessive congenital hereditary endothelial dystrophy (CHED) and autosomal dominant CHED are genetically distinct.
Br J Ophthalmol 1999;83115- 119
PubMedGoogle Scholar 119.Toma
NMEbenezer
NDInglehearn
CFPlant
CFicker
LABhattacharya
SS Linkage of congenital hereditary endothelial dystrophy to chromosome 20.
Hum Mol Genet 1995;42395- 2398
PubMedGoogle Scholar 120.Vithana
ENMorgan
PSundaresan
P
et al. Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2).
Nat Genet 2006;38755- 757
PubMedGoogle Scholar 121.Heon
EMathers
WDAlward
WL
et al. Linkage of posterior polymorphous corneal dystrophy to 20q11.
Hum Mol Genet 1995;4485- 488
PubMedGoogle Scholar 122.Heon
EGreenberg
AKopp
KK
et al.
VSX1: a gene for posterior polymorphous dystrophy and keratoconus.
Hum Mol Genet 2002;111029- 1036
PubMedGoogle Scholar 123.Semina
EVMintz-Hittner
HAMurray
JC Isolation and characterization of a novel human paired-like homeodomain-containing transcription factor gene,
VSX1, expressed in ocular tissues.
Genomics 2000;63289- 293
PubMedGoogle Scholar 124.Gwilliam
RLiskova
PFilipec
M
et al. Posterior polymorphous corneal dystrophy in Czech families maps to chromosome 20 and excludes the
VSX1 gene.
Invest Ophthalmol Vis Sci 2005;464480- 4484
PubMedGoogle Scholar 125.Aldave
AJYellore
VSPrincipe
AH
et al. Candidate gene screening for posterior polymorphous dystrophy.
Cornea 2005;24151- 155
PubMedGoogle Scholar 126.Bisceglia
LCiaschetti
MDe Bonis
P
et al. VSX1 mutational analysis in a series of Italian patients affected by keratoconus: detection of a novel mutation.
Invest Ophthalmol Vis Sci 2005;4639- 45
PubMedGoogle Scholar 127.Yellore
VSRayner
SAEmmert-Buck
L
et al. No pathogenic mutations identified in the
COL8A2 gene or four positional candidate genes in patients with posterior polymorphous corneal dystrophy.
Invest Ophthalmol Vis Sci 2005;461599- 1603
PubMedGoogle Scholar 128.Boruchoff
SAKuwabara
T Electron microscopy of posterior polymorphous degeneration.
Am J Ophthalmol 1971;72879- 887
PubMedGoogle Scholar 129.Henriquez
ASKenyon
KRDohlman
CH
et al. Morphologic characteristics of posterior polymorphous dystrophy: a study of nine corneas and review of the literature.
Surv Ophthalmol 1984;29139- 147
PubMedGoogle Scholar 130.Frisch
SM E1a induces the expression of epithelial characteristics.
J Cell Biol 1994;1271085- 1096
PubMedGoogle Scholar 131.Grooteclaes
MLFrisch
SM Evidence for a function of CtBP in epithelial gene regulation and anoikis.
Oncogene 2000;193823- 3828
PubMedGoogle Scholar 132.Schmid
ELisch
WPhilipp
W
et al. A new, X-linked endothelial corneal dystrophy.
Am J Ophthalmol 2006;141478- 487
PubMedGoogle Scholar 133.Aldave
AJLin
DYPrincipe
AHYellore
VSWeissman
BA Anterior basement membrane corneal dystrophy and pseudo-unilateral lattice corneal dystrophy in a patient with recurrent corneal erosions.
Am J Ophthalmol 2004;1371124- 1127
PubMedGoogle Scholar 134.Aldave
AJPrincipe
AHLin
DYYellore
VSSmall
KW Lattice dystrophy-like localized amyloidosis of the cornea secondary to trichiasis.
Cornea 2005;24112- 115
PubMedGoogle Scholar 135.Ameye
LYoung
MF Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy,and corneal diseases.
Glycobiology 2002;12107R- 116R
PubMedGoogle Scholar 136.Hopfer
UFukai
NHopfer
H
et al. Targeted disruption of
Col8a1 and
Col8a2 genes in mice leads to anterior segment abnormalities in the eye.
FASEB J 2005;191232- 1244
PubMedGoogle Scholar 137.Ohtoshi
AWang
SWMaeda
H
et al. Regulation of retinal cone bipolar cell differentiation and photopic vision by the CVC homeobox gene
Vsx1.
Curr Biol 2004;14530- 536
PubMedGoogle Scholar 138.Schorderet
DFMenasche
MMorand
S
et al. Genomic characterization and embryonic expression of the mouse Bigh3(
Tgfbi) gene.
Biochem Biophys Res Commun 2000;274267- 274
PubMedGoogle Scholar 139.Kanai
A The pathogenesis and treatment of corneal disorders [in Japanese].
Nippon Ganka Gakkai Zasshi 2002;106757- 777
PubMedGoogle Scholar